Hhlr Advisors, Ltd. Novavax Inc Transaction History

Hhlr Advisors, Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$78.74 - $139.5 $30.3 Million - $53.7 Million	-385,158 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$79.44 - $178.51 $4.7 Million - $10.6 Million	59,120 Added 18.13%	385,158 $41.7 Million
Q2 2020 Aug 14, 2020	BUY	$13.86 - $83.61 $4.52 Million - $27.3 Million	326,038 New	326,038 $27.2 Million

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $704M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Hhlr Advisors, Ltd., based on Form 13F filings with the SEC.

Stay updated on Hhlr Advisors, Ltd. with notifications on news.